Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07359664

OCTA in Cardiovascular Disease and Healthy Controls

Optical Coherence Tomography Angiography (OCTA) for the Assessment of Retinal Capillary Density in Patients With Cardiovascular Disease and a Healthy Control Group

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.

Detailed description

Each patient (32 patients) and healthy individual (32 healthy individuals) undergoes one study visit. After providing informed consent, each patient and healthy individual receives an assessment of their retinal vessels using OCTA and SLDF. In the sub-study of 10 patients with cardiovascular disease, the reliability of the OCTA measurements will be determined. Each patient will receive three study visits (with an OCTA and SLDF assessment on each occasion) on three different days.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRetinal vascular assessment using OCTA and SLDFAssessment of retinal capillary density using OCTA and SLDF

Timeline

Start date
2025-12-01
Primary completion
2026-12-01
Completion
2027-03-01
First posted
2026-01-22
Last updated
2026-01-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT07359664. Inclusion in this directory is not an endorsement.